Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2009-09-29
2010-12-21
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S325500
Reexamination Certificate
active
07855221
ABSTRACT:
The invention provides a crystalline freebase form of 4′-{2-ethoxy-4-ethyl-5-[((S)-2-mercapto-4-methylpentanoylamino)methyl]imidazol-1-ylmethyl}-3′-fluorobiphenyl-2-carboxylic acid. This invention also provides pharmaceutical compositions comprising the crystalline compound, processes and intermediates for preparing the crystalline compound, and methods of using the crystalline compound to treat diseases such as hypertension.
REFERENCES:
patent: 5444081 (1995-08-01), Gleason et al.
patent: 2004/0048911 (2004-03-01), Reitz et al.
patent: 2008/0269305 (2008-10-01), Allegretti et al.
patent: 2009/0023228 (2009-01-01), Allegretti et al.
PCT Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration for PCT/US2009/058803.
Chao Robert S.
Zhang Weijiang
Eberle Shelley
Hagenah Jeffrey A.
Saeed Kamal A
Shterengarts Samantha L
Theravance Inc.
LandOfFree
Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4187593